2007
DOI: 10.1136/jmg.2007.052027
|View full text |Cite
|
Sign up to set email alerts
|

Mutation analysis of NPHP6/CEP290 in patients with Joubert syndrome and Senior Loken syndrome

Abstract: Six novel and six known truncating mutations, one known missense mutation and one novel 3 bp pair in-frame deletion were identified in a total of seven families with JBTS, two families with SLSN and one family with isolated NPHP.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
73
0
1

Year Published

2009
2009
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 95 publications
(79 citation statements)
references
References 31 publications
(40 reference statements)
5
73
0
1
Order By: Relevance
“…On the surface, the association between ARL13B and JS is consistent with the hypothesis that Joubert syndrome and related disorders (JSRD) are ciliopathy disorders, or diseases caused by ciliary defects (Bielas et al, 2009;Cantagrel et al, 2008;Castori et al, 2005;Dixon-Salazar et al, 2004;Gleeson et al, 2004;Gorden et al, 2008;Harris, 2007;Helou et al, 2007;Jacoby et al, 2009;Sharma et al, 2008;Utsch et al, 2006;Wolf et al, 2007). However, phenotypical analysis of patients with ARL13B mutations and sequence analysis of the ARL13B gene in patients with non-classical forms of JS seem to suggest that mutations in ARL13B are restricted to the classical form of JS, with symptoms predominantly limited to brain structure and function (Cantagrel et al, 2008).…”
Section: Introductionsupporting
confidence: 55%
See 1 more Smart Citation
“…On the surface, the association between ARL13B and JS is consistent with the hypothesis that Joubert syndrome and related disorders (JSRD) are ciliopathy disorders, or diseases caused by ciliary defects (Bielas et al, 2009;Cantagrel et al, 2008;Castori et al, 2005;Dixon-Salazar et al, 2004;Gleeson et al, 2004;Gorden et al, 2008;Harris, 2007;Helou et al, 2007;Jacoby et al, 2009;Sharma et al, 2008;Utsch et al, 2006;Wolf et al, 2007). However, phenotypical analysis of patients with ARL13B mutations and sequence analysis of the ARL13B gene in patients with non-classical forms of JS seem to suggest that mutations in ARL13B are restricted to the classical form of JS, with symptoms predominantly limited to brain structure and function (Cantagrel et al, 2008).…”
Section: Introductionsupporting
confidence: 55%
“…The 'molar tooth sign' (MTS) in brain MRI scans resulting from structural abnormalities in the cerebellar vermis is a hallmark of classical JS (Gleeson et al, 2004;Harris, 2007;Sharma et al, 2008). As MTS can be found in patients with additional symptoms associated with ciliary defects, it is thought that ciliary defects might be the underlying mechanism of JSRD defects (Cantagrel et al, 2008;Castori et al, 2005;Dixon-Salazar et al, 2004;Gleeson et al, 2004;Gorden et al, 2008;Harris, 2007;Helou et al, 2007;Sharma et al, 2008;Utsch et al, 2006;Wolf et al, 2007). The findings that mutations in ARL13B are associated with JS and that Arl13b is required for cilia formation support this model.…”
Section: Discussionmentioning
confidence: 99%
“…A recent selective screen of 13 LCA genes in 60 affected subjects revealed a striking 43% of the mutant alleles in Cep290 (24), suggesting a significant contribution of this gene to retinal disease manifestation. In addition, mutations in Cep290 produce varying clinical outcomes of JBTS (25)(26)(27), MKS (28)(29)(30), and BBS (31). Cep290 has been implicated in ciliogenesis (32,33), which requires docking of the basal body to the plasma membrane and assembly of the BBSome (15) and chaperonin complexes (17).…”
Section: Introductionmentioning
confidence: 99%
“…CEP290 mutations have been described in up to 20% of cases of the devastating inherited blinding disease Leber congenital amaurosis (7,8) and in numerous cases of other more debilitating ciliopathies, such as Joubert syndrome (9-11), Senior-Løken syndrome (12), and Meckel-Gruber syndrome (13). How the many identified mutations in CEP290 contribute to these diverse pathologies remains unknown, and the protein's normal biological role has not been well characterized.…”
Section: Introductionmentioning
confidence: 99%